Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00473616
Status:
TERMINATED
Last Update Posted:
2011-02-11
First Post:
2007-05-14
Brief Title:
Phase I Single Ascending DoseMultiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D1040C00004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
MSD
Old Organization:
AstraZeneca